Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

Anton Hagenbeek, Hans Mooij, Josée Zijlstra, Pieternella Lugtenburg, Gustaaf van Imhoff, Marcel Nijland, Sanne Tonino, Martin Hutchings, Marjolein Spiering, Roberto Liu, Harm van Tinteren, Marie José Kersten

Research output: Contribution to journalLetterAcademicpeer-review

19 Citations (Scopus)
70 Downloads (Pure)
Original languageEnglish
Pages (from-to)e151-e153
Number of pages3
Issue number4
Publication statusPublished - 31-Mar-2019

Cite this